Thrivent Financial for Lutherans’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Sell |
4,379
-139
| -3% | -$33.6K | ﹤0.01% | 1748 |
|
|
2025
Q1 | $1.1M | Sell |
4,518
-12
| -0.3% | -$2.92K | ﹤0.01% | 1646 |
|
|
2024
Q4 | $1.49M | Buy |
4,530
+32
| +0.7% | +$10.5K | ﹤0.01% | 1647 |
|
|
2024
Q3 | $1.51M | Buy |
4,498
+3,675
| +447% | +$1.23M | ﹤0.01% | 1649 |
|
|
2024
Q2 | $225K | Sell |
823
-2,735
| -77% | -$748K | ﹤0.01% | 2462 |
|
|
2024
Q1 | $1.23M | Sell |
3,558
-16
| -0.4% | -$5.53K | ﹤0.01% | 1769 |
|
|
2023
Q4 | $1.15M | Sell |
3,574
-246
| -6% | -$79.4K | ﹤0.01% | 1748 |
|
|
2023
Q3 | $1.37M | Sell |
3,820
-7,747
| -67% | -$2.78M | ﹤0.01% | 1553 |
|
|
2023
Q2 | $4.39M | Buy |
11,567
+7,777
| +205% | +$2.95M | 0.01% | 910 |
|
|
2023
Q1 | $1.82M | Buy |
3,790
+2
| +0.1% | +$958 | ﹤0.01% | 1361 |
|
|
2022
Q4 | $1.59M | Sell |
3,788
-3,741
| -50% | -$1.57M | ﹤0.01% | 1410 |
|
|
2022
Q3 | $3.14M | Sell |
7,529
-4
| -0.1% | -$1.67K | 0.01% | 968 |
|
|
2022
Q2 | $3.73M | Sell |
7,533
-1,697
| -18% | -$840K | 0.01% | 921 |
|
|
2022
Q1 | $5.2M | Buy |
9,230
+3,835
| +71% | +$2.16M | 0.01% | 879 |
|
|
2021
Q4 | $4.08M | Sell |
5,395
-430
| -7% | -$325K | 0.01% | 985 |
|
|
2021
Q3 | $4.35M | Sell |
5,825
-18
| -0.3% | -$13.4K | 0.01% | 951 |
|
|
2021
Q2 | $3.77M | Buy |
5,843
+2
| +0% | +$1.29K | 0.01% | 1050 |
|
|
2021
Q1 | $3.34M | Sell |
5,841
-643
| -10% | -$367K | 0.01% | 1105 |
|
|
2020
Q4 | $3.78M | Sell |
6,484
-13,152
| -67% | -$7.67M | 0.01% | 977 |
|
|
2020
Q3 | $10.1M | Buy |
19,636
+2,728
| +16% | +$1.41M | 0.03% | 594 |
|
|
2020
Q2 | $7.63M | Sell |
16,908
-23,391
| -58% | -$10.6M | 0.02% | 613 |
|
|
2020
Q1 | $14.1M | Sell |
40,299
-28,612
| -42% | -$10M | 0.05% | 398 |
|
|
2019
Q4 | $25.5M | Buy |
68,911
+46,927
| +213% | +$17.4M | 0.07% | 316 |
|
|
2019
Q3 | $7.32M | Buy |
21,984
+9,496
| +76% | +$3.16M | 0.02% | 582 |
|
|
2019
Q2 | $3.9M | Buy |
12,488
+86
| +0.7% | +$26.9K | 0.01% | 741 |
|
|
2019
Q1 | $3.79M | Buy |
12,402
+7,313
| +144% | +$2.24M | 0.01% | 748 |
|
|
2018
Q4 | $1.18M | Buy |
5,089
+221
| +5% | +$51.3K | ﹤0.01% | 1063 |
|
|
2018
Q3 | $1.52M | Buy |
4,868
+253
| +5% | +$79.2K | ﹤0.01% | 1025 |
|
|
2018
Q2 | $1.33M | Buy |
4,615
+35
| +0.8% | +$10.1K | ﹤0.01% | 1082 |
|
|
2018
Q1 | $1.15M | Buy |
4,580
+162
| +4% | +$40.5K | ﹤0.01% | 1159 |
|
|
2017
Q4 | $1.05M | Buy |
4,418
+148
| +3% | +$35.3K | ﹤0.01% | 1221 |
|
|
2017
Q3 | $949K | Buy |
4,270
+70
| +2% | +$15.6K | ﹤0.01% | 1198 |
|
|
2017
Q2 | $950K | Buy |
4,200
+290
| +7% | +$65.6K | ﹤0.01% | 1152 |
|
|
2017
Q1 | $779K | Buy |
3,910
+350
| +10% | +$69.7K | ﹤0.01% | 1309 |
|
|
2016
Q4 | $649K | Buy |
3,560
+310
| +10% | +$56.5K | ﹤0.01% | 1378 |
|
|
2016
Q3 | $532K | Sell |
3,250
-10,410
| -76% | -$1.7M | ﹤0.01% | 1426 |
|
|
2016
Q2 | $1.95M | Buy |
13,660
+310
| +2% | +$44.3K | 0.01% | 873 |
|
|
2016
Q1 | $1.83M | Buy |
13,350
+280
| +2% | +$38.3K | 0.01% | 893 |
|
|
2015
Q4 | $1.81M | Buy |
13,070
+10,770
| +468% | +$1.49M | 0.01% | 880 |
|
|
2015
Q3 | $309K | Buy |
2,300
+200
| +10% | +$26.9K | ﹤0.01% | 1429 |
|
|
2015
Q2 | $316K | Buy |
2,100
+500
| +31% | +$75.2K | ﹤0.01% | 1369 |
|
|
2015
Q1 | $216K | Buy |
+1,600
| New | +$216K | ﹤0.01% | 1562 |
|